These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11311194)

  • 1. Lipid-lowering interventions in managed care settings.
    Fox J; Jones K
    Am J Med; 2001 Apr; 110 Suppl 6A():24S-30S. PubMed ID: 11311194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic benefits of aggressive lipid lowering: a managed care perspective.
    McKenney JM; Kinosian B
    Am J Manag Care; 1998 Jan; 4(1):65-74. PubMed ID: 10179907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the results: phase 1 hyperlipidemia outcomes in 27 health plans.
    Latts LM
    Am J Med; 2001 Apr; 110 Suppl 6A():17S-23S. PubMed ID: 11311193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A means to an end: an overview of a hyperlipidemia outcomes management program.
    Patel B; Perez HE
    Am J Med; 2001 Apr; 110 Suppl 6A():12S-16S. PubMed ID: 11311192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical context: current concepts of coronary heart disease management.
    Jacobson TA
    Am J Med; 2001 Apr; 110 Suppl 6A():3S-11S. PubMed ID: 11311191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful management of lipid-lowering programs.
    Wright AT
    Manag Care; 2001 Nov; 10(11 Suppl):10-3; discussion 19-24. PubMed ID: 11761624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing dyslipidemia in the high-risk patient.
    Stein EA
    Am J Cardiol; 2002 Mar; 89(5A):50C-57C. PubMed ID: 11900720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinics: the alliance study.
    Koren MJ; Hunninghake DB;
    J Am Coll Cardiol; 2004 Nov; 44(9):1772-9. PubMed ID: 15519006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost of treating dyslipidaemia using National Cholesterol Education Program (NCEP) guidelines.
    McKenney JM
    Pharmacoeconomics; 1998; 14 Suppl 3():19-28. PubMed ID: 10346425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human and economic costs of undertreatment with statins.
    Durrington P
    Int J Clin Pract; 2002 Jun; 56(5):357-68. PubMed ID: 12137445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary prevention.
    Am J Manag Care; 1998 Apr; 4(4 Suppl):S185-90. PubMed ID: 10184933
    [No Abstract]   [Full Text] [Related]  

  • 12. Achieving cholesterol target in a managed care organization (ACTION) trial.
    Straka RJ; Taheri R; Cooper SL; Smith JC
    Pharmacotherapy; 2005 Mar; 25(3):360-71. PubMed ID: 15843283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid management in a private cardiology practice (the Midwest Heart experience).
    Brown AS; Cofer LA
    Am J Cardiol; 2000 Feb; 85(3A):18A-22A. PubMed ID: 10695703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol: precursor to many lipid disorders.
    Jones PH
    Am J Manag Care; 2001 Aug; 7(9 Suppl):S289-98. PubMed ID: 11517815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns and effectiveness of lipid-lowering therapies in a managed care environment.
    Meyer JW; Schultz JS; O'Donnell JC; Patel PA; Sasane RM
    Value Health; 2005; 8(5):601-12. PubMed ID: 16176498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary prevention in a cardiology group practice and hospital setting after a heart-care initiative.
    LaBresh KA; Owen P; Alteri C; Reilly S; Albright PS; Hordes AR; Shaftel PA; Noonan TE; Stoukides CA; Kaul AF
    Am J Cardiol; 2000 Feb; 85(3A):23A-29A. PubMed ID: 10695704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of dyslipidemia in the high-risk patient.
    Stein EA
    Am Heart J; 2002 Dec; 144(6 Suppl):S43-50. PubMed ID: 12486415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on the management of dyslipidemia.
    Irons BK; Snella KA; McCall K; MacLaughlin EJ; Villarreal M
    Am J Health Syst Pharm; 2002 Sep; 59(17):1615-25. PubMed ID: 12224342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current lipid management and low cholesterol goal attainment in common daily practice in Spain. The REALITY Study.
    García Ruiz FJ; Marín Ibáñez A; Pérez-Jiménez F; Pintó X; Nocea G; Ahumada C; Alemao E; Yin D;
    Pharmacoeconomics; 2004; 22 Suppl 3():1-12. PubMed ID: 15669149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic efficacy of the lipid-lowering armamentarium: the clinical benefits of aggressive lipid-lowering therapy.
    Hunninghake DB
    Am J Med; 1998 Feb; 104(2A):9S-13S. PubMed ID: 9550501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.